A recent study in eClinicalMedicine found that fecal microbiota transplantation, combined with fruquintinib and tislelizumab, significantly improved survival rates in patients with microsatellite stable metastatic colorectal cancer, showing manageable safety and notable increases in progression-free and overall survival.
Study finds link between epimutations in BRCA1 gene and triple-negative breast cancer risk
Research reveals that around 20 per cent of all cases of the most severe form of breast cancer may arise from the small group of
December 7, 2023